Companies / Champions Oncology, Inc. / Activity
Activity — Champions Oncology, Inc.
10 moves.
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jul 16, 2025 | Brainin Robert Lawrence CEO | Grant | Option to purchase Common Stock | — | +100K +14.83% | 774,163 5.57% of shares | low |
| Jul 16, 2025 | Brainin Robert Lawrence CEO | Grant | Option to purchase Common Stock | — | +100K +17.42% | 674,163 4.85% of shares | low |
| Jul 16, 2025 | Brainin Robert Lawrence CEO | Grant | Option to purchase Common Stock | — | +150K +35.36% | 574,163 4.13% of shares | low |
| Jul 16, 2025 | Brainin Robert Lawrence CEO | Grant | Option to purchase Common Stock | — | +63K +17.28% | 424,163 3.05% of shares | low |
| Jul 16, 2025 | Brainin Robert Lawrence CEO | Grant | Option to purchase Common Stock | — | +63K +20.89% | 361,663 2.60% of shares | low |
| Jul 16, 2025 | Brainin Robert Lawrence CEO | Grant | Option to purchase Common Stock | — | +225K +303.39% | 299,163 2.15% of shares | low |
| Nov 12, 2024 | Brainin Robert Lawrence CEO | Grant | Option to purchase Common Stock | — | +23K +45.04% | 74,163 0.53% of shares | low |
| Nov 3, 2023 | Brainin Robert Lawrence CEO | Grant | Option to purchase Common Stock | — | +19K +59.48% | 51,133 0.37% of shares | low |
| Nov 1, 2022 | Brainin Robert Lawrence CEO | Grant | Option to purchase Common Stock | — | +14K +78.79% | 32,063 0.23% of shares | low |
| Nov 5, 2021 | Brainin Robert Lawrence CEO | Grant | Option to purchase Common Stock | — | +10K +123.27% | 17,933 0.13% of shares | low |